ArticleEuropean archives of psychiatry and clinical neuroscience2025
Higher neutrophil-lymphocyte ratio predicts poor response to repetetive transcranial magnetic stimulation(rTMS) in treatment resistant depression.
Article in European archives of psychiatry and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond inflammatory markers: immunometabolic phenotypes for precision stratification in psychiatry.European archives of psychiatry and clinical neuroscience · 2026Article
- Repetitive trans-spinal magnetic stimulation promotes repair in inflammatory spinal cord injury through sex-dependent immune modulation.Journal of neuroinflammation · 2026Article
- rTMS for rapid relief of sleep disorders induced by influenza virus infection: a clinical retrospective study.Translational psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Repetitive transcranial magnetic stimulation (rTMS) has emerged as a noninvasive therapy for treatment resistant depression (TRD). The results of studies on the mechanism of rTMS and the predictive parameters for determining which patients will respond to rTMS are inconclusive. This study aims to investigate the relationship between pre-treatment systemic inflammatory markers and the response to rTMS in TRD patients. We retrospectively reviewed 86 patients with TRD who received 10 Hz rTMS to the left dorsolateral prefrontal cortex (DLPFC) at Gazi University between June 2017 and June 2023. Inflammatory markers, including neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and systemic immune-inflammatory index (SII), were evaluated. Treatment response was assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS), with a ≥50% reduction in MADRS score and a score ≤8 at the end of treatment considered as a positive response. Patients divided in to two groups accoording to rTMS response. 53 patients were responders and 33 patients were non-responders. Significant differences in inflammatory parameters were observed, with non-responders showing higher NLR (p=0.001), PLR (p=0.008), and SII (p=0.002) values. Logistic regression analysis revealed that higher NLR was significantly associated with a poorer response to rTMS (OR=0.373, p=0.022). Additionally, early improvement in MADRS score in the first week predicted overall treatment outcome (OR=1.070, p<0.001). Our findings suggest that systemic inflammation plays a role in TRD and that higher pre-treatment NLR is associated with a poorer response to rTMS. Largerscale studies are needed to further understand the mechanisms and improve treatment strategies for TRD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.